Primary care doctors and patients frustrated as telehealth companies restrict access to obesity drugs
By
Sydney Lupkin
Summary
The article examines the growing tension between primary care doctors and telehealth companies like Vida Health over obesity drugs such as Zepbound. Telehealth companies are being hired by employers to provide lifestyle support for patients taking weight-loss drugs, but also to help control costs by limiting access to the expensive medications. The piece highlights the frustration of patients like David Davis, who must navigate additional hurdles set by telehealth providers even after receiving a prescription from their primary care doctor, raising concerns about the role of these companies in patient care and drug access.
Source
bskyPrimary care doctors and patients frustrated as telehealth companies restrict access to obesity drugsn.prKey quotes
· 3 pulledEvery time David Davis talks to a nurse at Vida Health, he thinks he'll finally get the OK for Zepbound. And every time so far he has been wrong.
I thought, 'All right, I'll go through their hoops — I'll jump through their hoops.' The more they wanted, the more frustrated I would get.
Employers also want the telehealth providers to limit spending on the drugs.
You might also wanna read
Senators Investigate Pharmaceutical Companies' Direct-to-Consumer Telehealth Platforms for Steering Patients to High-Cost Drugs
U.S. senators are investigating direct-to-consumer (DTC) telehealth platforms operated by pharmaceutical companies like Eli Lilly and Pfizer
arstechnica.com·4mo ago
Experts warn easy access to GLP-1 drugs may increase eating disorder risks
Experts are raising concerns that the widespread availability of GLP-1 drugs (like Ozempic and Wegovy) through telemedicine and oral formula
mdsc.pe·1d ago
Personal Reflection on Using Proprietary Medical Devices for Diabetes Management
The article discusses the author's personal experience with diabetes and their difficult choice to use a proprietary continuous glucose moni
sfconservancy.org·5mo ago
Insurance Denials for Eating Disorder Treatment Persist Despite Mental Health Parity Law
This investigative report examines how insurance companies are exploiting loopholes in the Mental Health Parity and Addiction Equity Act to
Rolling Stone·12d ago
Research Reveals Persistent Drug Pricing Distortions from PBM-Owned Pharmaceutical Companies
The article examines the persistent distortions in U.S. drug pricing, particularly focusing on vertically integrated pharmacy benefit manage
46brooklyn.com·7mo ago
Insurance Companies' 'Downcoding' Practices Create Conflict with Healthcare Providers
This article examines the growing conflict between healthcare providers and insurance companies over 'downcoding' practices, where insurers
nbcnews.com·8mo ago